EUVIMEDEUVIMED entdecken
Open Access

Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Victor Santoro-Fernandes, Brayden Schott, Amy J Weisman, Ojaswita Lokre, Steve Y Cho, Scott B Perlman, Timothy G Perk, Robert Jeraj

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.267809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Victor Santoro-Fernandes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Radiopharmaceuticals, Octreotide, Receptors, Peptide. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsRadiopharmaceuticalsOctreotideReceptors, PeptideHumansMaleFemalePositron Emission Tomography Computed TomographyMiddle AgedRetrospective StudiesAgedOrganometallic CompoundsNeoplasm MetastasisTreatment OutcomeAdult

Stichwörter der Autor:innen

PET/CTneuroendocrine tumorpeptide receptor radiopharmaceutical therapyresponse heterogeneitytheranosticstreatment response assessment

Substanzen

RadiopharmaceuticalsOctreotideOrganometallic CompoundsReceptors, Peptidelutetium Lu 177 dotatate

Autor:innen und Institutionen

  • Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.
  • AIQ Solutions, Madison, Wisconsin.
  • Section of Nuclear Medicine and Molecular Imaging, Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; and.
  • Carbone Cancer Centre, University of Wisconsin, Madison, Wisconsin.
  • Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; rjeraj@wisc.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Santoro-Fernandes, V., Schott, B., Weisman, A. J., Lokre, O., Cho, S. Y., Perlman, S. B., Perk, T. G., & Jeraj, R. (2025). Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267809

Vancouver

Santoro-Fernandes V, Schott B, Weisman AJ, Lokre O, Cho SY, Perlman SB, et al. Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.267809

BibTeX
@article{SantoroFernandes2025,
  author = {Santoro-Fernandes, Victor and Schott, Brayden and Weisman, Amy J and Lokre, Ojaswita and Cho, Steve Y and Perlman, Scott B and Perk, Timothy G and Jeraj, Robert},
  title = {Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.267809}
}
Kostenlos starten →